| Literature DB >> 30005599 |
Mailan Natarajan1, Deepika Kumar1, Jharna Mandal2, Niranjan Biswal3, Selvaraj Stephen4.
Abstract
BACKGROUND: Emergence of atypical enteropathogenic Escherichia coli (EPEC) and hybrid E. coli (harboring genes of more than one DEC pathotypes) strains have complicated the issue of growing antibiotic resistance in diarrhoeagenic Escherichia coli (DEC). This ongoing evolution occurs in nature predominantly via horizontal gene transfers involving the mobile genetic elements like integrons notably class 1 integron. This study was undertaken to determine the virulence pattern and antibiotic resistance among the circulating DEC strains in a tertiary care center in south of India.Entities:
Keywords: Adults; Antimicrobial resistance (AMR) genes; Children; Diarrhea; Diarrhoeagenic Escherichia coli (DEC)
Mesh:
Substances:
Year: 2018 PMID: 30005599 PMCID: PMC6045864 DOI: 10.1186/s41043-018-0147-z
Source DB: PubMed Journal: J Health Popul Nutr ISSN: 1606-0997 Impact factor: 2.000
Age groups and gender wise distribution of DEC pathotypes in children and adults
| DEC infection types | DEC pathotypes | Genes | DEC infection in children ( | DEC infection in adults ( | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender | Age in months (median* (IQR) − 12 (5.25–24)) | Gender | Age in years (mean [± SD] − 44.74 [±15.24]) | ||||||||||||
| Male | Female | 0–12 | 13–24 | 25–36 | 37–48 | 49–60 | Male | Female | 18–24 | 25–36 | 37–48 | 49–85 | |||
| Single DEC infection | Typical EPEC | 2 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Atypical EPEC |
| 3 | 2 | 2 | 2 | 1 | 0 | 0 | 1 | 3 | 0 | 1 | 1 | 2 | |
|
| 5 | 8 | 7 | 6 | 0 | 0 | 0 | 5 | 1 | 0 | 1 | 3 | 2 | ||
| ETEC |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 1 | 1 | 1 | |
|
| 2 | 4 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | ||
| EAEC |
| 3 | 2 | 2 | 3 | 0 | 0 | 0 | 1 | 1 | 0 | 2 | 0 | 0 | |
| EIEC |
| 0 | 3 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| STEC |
| 4 | 0 | 2 | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | |
| DEC Co-infection | Atypical EPEC + Atypical EPEC | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| EAEC + EIEC | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Atypical EPEC + STEC | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EPEC/ETEC (Hybrid DEC Strain) + atypical EPEC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | ||
| Hybrid DEC infection | EAEC/EPEC |
| 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EAEC/EIEC | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total | 25 | 20 | 21 | 20 | 1 | 1 | 2 | 12 | 6 | 1 | 5 | 5 | 7 | ||
| ( | ( | ||||||||||||||
DEC diarrhoeagenic E. coli, EPEC enteropathogenic E. coli, ETEC enterotoxigenic E. coli, EAEC enteroaggregative E. coli, STEC Shiga toxin-producing E. coli, EIEC enteroinvasive E. coli, NTEC necrotoxigenic E. coli, CDEC cell-detaching E. coli, IQR interquartile range, SD stranded deviation
*Age expressed in median (non-normally distribution)
AMR and integron genes in DEC strains isolated from children and adults
| AMR genes | AMR and integron genes in DEC strains with isolated from children | AMR and integron genes in DEC strains with isolated from adults | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEC single and co-infection | Hybrid DEC infection | Total | DEC single and co-infection | Hybrid infection | Total | |||||||||||||
| Typical EPEC | Atypical EPEC | ETEC | EIEC | EAEC | EHEC | EAEC + atypical EPEC | EHEC + EIEC | Atypical EPEC | ETEC | EAEC | EHEC | EPEC/ETEC (Hybrid) | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 0 | 2 | 6 | 3 | 1 | 4 | 0 | 0 | 1 | 1 | 18 | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
|
| 2 | 3 | 6 | 3 | 2 | 3 | 1 | 0 | 1 | 0 | 21 | 0 | 1 | 2 | 0 | 0 | 0 | 3 |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| qeqA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 0 | 4 | 9 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 23 | 0 | 1 | 1 | 2 | 0 | 0 | 4 |
|
| 3 | 5 | 14 | 5 | 3 | 5 | 4 | 0 | 1 | 0 | 40 | 0 | 2 | 0 | 2 | 0 | 0 | 4 |
|
| 2 | 4 | 9 | 3 | 2 | 4 | 3 | 1 | 0 | 1 | 29 | 1 | 3 | 1 | 2 | 1 | 0 | 8 |
|
| 0 | 1 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 6 | 1 | 1 | 1 | 1 | 0 | 0 | 4 |
|
| 3 | 1 | 6 | 3 | 2 | 4 | 2 | 1 | 1 | 1 | 24 | 0 | 1 | 0 | 2 | 0 | 0 | 3 |
|
| 0 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 4 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
|
| 1 | 1 | 4 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 10 | 0 | 2 | 2 | 0 | 0 | 0 | 4 |
|
| 0 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 1 | 2 | 4 | 2 | 0 | 1 | 1 | 0 | 1 | 0 | 12 | 1 | 1 | 0 | 1 | 0 | 0 | 3 |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 0 | 0 | 3 | 3 | 2 | 4 | 2 | 1 | 0 | 1 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 0 | 2 | 3 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 9 | 0 | 3 | 4 | 1 | 0 | 0 | 8 |
|
| 1 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 13 | 0 | 3 | 2 | 0 | 0 | 0 | 5 |
|
| 1 | 0 | 5 | 3 | 0 | 2 | 2 | 1 | 0 | 0 | 14 | 0 | 2 | 2 | 1 | 1 | 0 | 6 |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 1 | 4 | 9 | 3 | 4 | 6 | 2 | 1 | 1 | 1 | 32 | 0 | 2 | 1 | 0 | 0 | 0 | 3 |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DEC diarrhoeagenic E. coli, EPEC enteropathogenic E. coli, ETEC enterotoxigenic E. coli, EAEC enteroaggregative E. coli, EHEC enterohemorrhagic E. coli, EIEC enteroinvasive E. coli
The association between DEC pathotypes and antimicrobial resistance gene; odds ratio (OR) (95% confidence interval)
| AMR enes | EPEC | ETEC | EAEC | EIEC | EHEC | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| C | A | C | A | C | A | C | A | C | A | |
|
| 6.9 (2.38–20.30) | 0.0 (inf- inf) | 6.8 (1.26–36.84) | inf. (inf- inf) | 25.7 (4.66–142.14) | 0.0 (inf- inf) | 1.4 (0.16–14.10) | – | 0.0 (inf- inf) | 0.0 (inf- inf) |
|
| 8.3 (2.99–23.52) | 8.7 (1.10–68.70) | 5.5 (1.03–29.43) | 31.3 (3.23–303.96) | 5.7 (1.31–25.29) | 0.0 (inf- inf) | 3.4 (0.54–22.21) | – | 0.9 (0.11–8.76) | 0.0 (inf- inf) |
|
| 15.1 (5.24–43.89) | 2.6 (0.25–27.29) | 2.2 (0.39–13.31) | 7.7 (0.65–92.05) | 5.0 (1.16–21.99) | inf. (inf- inf) | 7.3 (1.15–46.87) | – | 2.2 (0.39–13.31) | 0.0 (inf- inf) |
|
| 36.0 ((9.71–133.99) | 8.7 (1.10–68.70) | 11.7 (1.32–103.96) | 0.0 (inf- inf) | 7.1 (1.37–37.20) | inf. (inf- inf) | 3.2 (0.53–20.49) | – | 4.5 (0.79–25.70) | 0.0 (inf- inf) |
|
| 10.3 (3.87–27.62) | 10.6 (2.22–50.77) | 3.5 (0.67–18.38) | 3.1 (0.31–32.42) | 6.3 (1.41–28.33) | inf. (inf- inf) | 5.3 (0.84–33.47) | – | 7.3 (1.27–42.52) | inf. (inf- inf) |
|
| 22.8 (2.54–205.95) | 5.7 (0.85–38.54) | 4.4 (0.44–45.88) | 20.6 (2.46–173.35) | 3.1 (0.32–30.69) | 23.7 (1.25–452.35) | 0.0 (inf- inf) | – | 0.0 (inf- inf) | 0.0 (inf- inf) |
|
| 6.0 (2.28–16.17) | 3.9 (0.33–47.27) | 4.5 (0.86–24.25) | 0.0 (inf- inf) | 16.1 (3.02–86.53) | -inf. (inf- inf) | 6.9 (1.09–44.08) | – | 4.5 (0.86–24.25) | 0.0 (inf- inf) |
| aac | 4.2 (0.98–18.23) | – | 9.2 (1.40–60.97) | – | 2.2 (0.24–20.51) | – | 3.9 (0.39–40.37) | – | 0.0 (inf- inf) | – |
|
| 1.2 (0.12–12.57) | 0.0 (inf- inf) | 7.6 (0.67–86.67) | inf. (inf- inf) | 5.3 (0.49–58.12) | 0.0 (inf- inf) | 0.0 (inf- inf) | – | 7.6 (0.67–86.67) | – |
|
| 21.1 (4.14–107.68) | 8.7 (1.10–68.70) | 0.0 (inf- inf) | 31.3 (3.23–303.96) | 4.4 (0.77–25.76) | 0.0 (inf- inf) | 9.1 (1.33–63.02) | – | 2.4 (0.25–22.82) | 0.0 (inf- inf) |
|
| 1.9 (0.33–11.21) | – | 0.0 (inf- inf) | – | 3.1 (0.32–30.69) | – | 19.0 (2.45–147.34) | – | 4.4 (0.44–45.88) | – |
|
| 10.3 (2.81–37.99) | 17.6 (1.46–211.86) | 5.3 (0.87–32.92) | 0.0 (inf- inf) | 3.5 (0.62–19.68) | 48.5 (2.17–1082.45) | 0.0 (inf- inf) | – | 1.9 (0.21–18.01) | 0.0 (inf- inf) |
|
| 1.2 (0.38–4.38) | 0.0 (inf- inf) | 8.0 (1.46–43.84) | -inf. (inf- inf) | 15.7 (3.31–75.02) | 0.0 (inf- inf) | 12.1 (1.85–79.38 | – | 8.0 (1.46–43.84) | 0.0 (inf- inf) |
|
| 9.4 (2.17–40.78) | 4.6 (0.98–21.67) | 0.0 (inf- inf) | 72.8 (6.81–778.05) | 5.1 (0.87–30.30) | -inf. (inf- inf) | 3.4 (0.34–34.49) | – | 2.7 (0.28–26.22) | 0.0 (inf- inf) |
|
| 3.3 (1.04–10.69) | 3.3 (0.57–19.65) | 5.3 (2.00–14.14) | 12.1 (1.64–89.92) | 2.8 (0.52–15.79) | -inf. (inf- inf) | 2.0 (0.21–19.46) | – | 9.6 (1.73–53.63) | -inf. (inf- inf) |
|
| 3.8 (1.17–12.72) | 14.5 (2.13–98.54) | 10.7 (1.90–60.15) | 20.6 (2.46–173.35) | 11.7 (2.51–55.16) | 0.0 (inf- inf) | 2.2 (0.23–21.40) | – | 1.7 (0.19–16.25) | 0.0 (inf- inf) |
|
| 8.1 (3.12–21.05) | 5.7 (0.85–38.54) | 3.0 (0.58–15.87) | 20.6 (2.46–173.35) | inf. (inf- inf) | 23.7 (1.25–452.35) | inf. (inf- inf) | – | 3.0 (0.58–15.87) | 0.0 (inf- inf) |
OR odds ratio, inf infinity, C children, A adults
Antibiogram of DEC isolates (n = 67)
| Antimicrobial class | Antimicrobials | Resistance | Intermediate | Sensitivity |
|---|---|---|---|---|
| β-lactam | Ceftriaxone | 33 (49.2%) | 1 (1.4%) | 33 (49.2%) |
| Ceftazidime | 18 (26.8%) | 10 (14.9%) | 39 (58.2%) | |
| Cefoperazone-sulbactam | 5 (7.4%) | 0 (0.0%) | 62 (92.5%) | |
| Trimethoprim and sulfonamides | Co-trimoxazole | 29 (43.2%) | 1 (1.4%) | 37 (55.2%) |
| Tetracycline | Tetracycline | 24 (35.8%) | 0 (0.0%) | 43 (64.1%) |
| Quinolones | Levofloxacin | 22 (32.8%) | 3 (4.4%) | 42 (62.6%) |
| Ciprofloxacin | 20 (29.8%) | 11 (16.4%) | 36 (53.7%) | |
| Aminoglycosides | Gentamicin | 13 (19.4%) | 2 (2.9%) | 52 (77.6%) |
| Amikacin | 5 (7.4%) | 1 (1.4%) | 61 (91%) | |
| Phenicol | Chloramphenicol | 9 (13.4%) | 2 (2.9%) | 56 (83.5%) |
DEC diarrhoeagenic E.coli
Correlation between phenotypic and genotypic resistance pattern of the DEC isolates (n = 67)
| Antimicrobial class | Antimicrobials | AMR genes detected | Pattern 1 | Pattern 2 | Pattern 3 | Pattern 4 |
|---|---|---|---|---|---|---|
| Quinolones | Ciprofloxacin and levofloxacin | 13 (19.4%) | 20 (29.8%) | 9 (13.4%) | 25 (37.3%) | |
| Aminoglycosides | Amikacin and gentamicin | 42 (62.6%) | 9 (13.4%) | 9 (13.4%) | 7 (10.29%) | |
| Tetracycline | Tetracycline |
| 25 (37.3%) | 13 (19.4%) | 18 (23.8%) | 11 (16.4%) |
| Phenicols | Chloramphenicol |
| 44 (65.6%) | 6 (8.9%) | 12 (17.9) | 5 (7.4%) |
| β-lactam | Ceftazidime, ceftriaxone, and cefoperazone-sulbactam | 15 (22.5%) | 16 (23.8%) | 13 (19.4%) | 23 (34.3%) | |
| Trimethoprim and sulfonamide | Co-trimoxazole | 9 (13.4%) | 1 (1.4%) | 28 (41.7%) | 29 (43.2%) |
Pattern 1: No resistance gene(s) detected and phenotypically sensitive
Pattern 2: No resistance gene(s) detected but phenotypically resistant
Pattern 3: Resistance gene(s) detected but phenotypically sensitive
Pattern 4: Resistance gene(s) detected and phenotypically resistant